| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |